Cargando…
Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex(®) intrauterine shunt
PURPOSE: The objective was to evaluate the feasibility of vesicoamniotic shunting (VAS) in the first trimester with the Somatex(®) intrauterine shunt and report on complications and neonatal outcome. METHODS: Retrospective cohort study of all VAS before 14 weeks at two tertiary fetal medicine centre...
Autores principales: | Strizek, B., Gottschalk, I., Recker, F., Weber, E., Flöck, A., Gembruch, U., Geipel, A., Berg, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266802/ https://www.ncbi.nlm.nih.gov/pubmed/32449061 http://dx.doi.org/10.1007/s00404-020-05598-z |
Ejemplares similares
-
Intrauterine Thoracoamniotic Shunting of Fetal Hydrothorax with the Somatex Intrauterine Shunt: Intrauterine Course and Postnatal Outcome
por: Grandt, Joleen, et al.
Publicado: (2022) -
Vesicoamniotic Shunting before 17 + 0 Weeks in Fetuses with Lower Urinary Tract Obstruction (LUTO): Comparison of Somatex vs. Harrison Shunt Systems
por: Strizek, Brigitte, et al.
Publicado: (2022) -
Management and outcome of prenatal absent pulmonary valve syndrome
por: Recker, Florian, et al.
Publicado: (2022) -
Fetal ciliopathies: a retrospective observational single-center study
por: Simonini, Corinna, et al.
Publicado: (2021) -
Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study
por: Kosian, Philipp, et al.
Publicado: (2022)